Matthew Rizzo - Director, 10%+ Owner at Xtant Medical Holdings, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director, 10%+ Owner
Stock Symbol
XTNT on NYSE
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Matthew Rizzo since 11/21/2023

Holdings reported by Matthew Rizzo for Xtant Medical Holdings, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock, $0.000001 par value 17.1M $10.4M $0.61 Aug 15, 2022 Indirect
Common Stock, $0.000001 par value 215K $131K $0.61 Aug 15, 2022 Direct

Transactions reported by Matthew Rizzo for Xtant Medical Holdings, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.